Kevin Coleman

Kevin Coleman has extensive work experience in business operations and administrative roles. Kevin started their career as an Executive Assistant in business development at Genicon Sciences in 2000 and later worked as an Administrative Assistant in Drug Development Consulting at PAREXEL from 2001 to 2006. Kevin then served as an Administrative Assistant in R&D at Verus Pharmaceuticals from 2006 to 2008.

From 2008 to 2015, Kevin worked at Meritage Pharma, Inc. as an Office Manager and Staff Accountant, and later as an Office Manager/Executive Assistant. In 2015, they joined Zavante Therapeutics, Inc. as an Administrative Consultant and progressed to become an Associate Director of Administrative Operations, a role they held until 2018.

Kevin then moved to Nabriva Therapeutics plc in 2018, where they initially worked as a Business Operations Consultant for the Zavante Subsidiary and later as an Associate Director of Administrative Operations. In 2019, they joined Medcura, Inc. as a Business Operations Consultant, supporting the CFO and overseeing the financial operations of the company.

In 2018, Kevin also worked at Oncternal Therapeutics as an Associate Director of Business Operations, responsible for the day-to-day operations of the company. Currently, they are serving as an Associate Director of Business Operations at Immusoft, starting in 2019.

Most recently, Kevin joined Ray Therapeutics, Inc. in 2021 as an Associate Director of Business Operations, a role they are expected to hold until 2023. Throughout their career, Kevin has demonstrated expertise in resolving complex problems, executing transactions, and participating in the development and implementation of products and systems in an operations environment.

Kevin Coleman attended the New England Banking Institute from 1989 to 1995. No specific degree or field of study was mentioned in the provided information.